{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:02:07Z","timestamp":1780758127105,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cellsig.2026.112602","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:34:02Z","timestamp":1778628842000},"page":"112602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ZNF503 reduces chemotherapy sensitivity in prostate cancer by activating ISL1 and Notch1 signaling"],"prefix":"10.1016","volume":"145","author":[{"given":"Yong","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyou","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liefu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7547","key":"10.1016\/j.cellsig.2026.112602_bb0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature14347","article-title":"The evolutionary history of lethal metastatic prostate cancer","volume":"520","author":"Gundem","year":"2015","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.cellsig.2026.112602_bb0010","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate Cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.cellsig.2026.112602_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100962","article-title":"Current therapy and drug resistance in metastatic castration-resistant prostate cancer","volume":"68","author":"Cai","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112602_bb0020","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41585-018-0060-7","article-title":"Landmarks in prostate cancer","volume":"15","author":"Sathianathen","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112602_bb0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bph.15300","article-title":"Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it","volume":"178","author":"Wang","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112602_bb0030","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1101\/gr.209643.116","article-title":"Multiparameter functional diversity of human C2H2 zinc finger proteins","volume":"26","author":"Schmitges","year":"2016","journal-title":"Genome Res."},{"key":"10.1016\/j.cellsig.2026.112602_bb0035","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/cddiscovery.2017.71","article-title":"Zinc-finger proteins in health and disease","volume":"3","author":"Cassandri","year":"2017","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112602_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020667","article-title":"Advances of zinc signaling studies in prostate Cancer","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112602_bb0045","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300801R","article-title":"The role of zinc finger proteins in malignant tumors","volume":"37","author":"Zhao","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2026.112602_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/CMAR.S431135","article-title":"ZNF217: an oncogenic transcription factor and potential therapeutic target for multiple human cancers","volume":"16","author":"Wang","year":"2024","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112602_bb0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41419-020-2422-3","article-title":"Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112602_bb0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13046-020-01770-0","article-title":"ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15","volume":"39","author":"Wang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112602_bb0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s11658-019-0161-1","article-title":"MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503","volume":"24","author":"Lu","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112602_bb0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13402-020-00563-z","article-title":"LncRNA ZNF503-AS1 acts AS a tumor suppressor in bladder cancer by up-regulating ca(2+) concentration via transcription factor GATA6","volume":"44","author":"He","year":"2021","journal-title":"Cell. Oncol. (Dordr.)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112602_bb0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2015.07.048","article-title":"Notch signaling: an emerging therapeutic target for cancer treatment","volume":"369","author":"Yuan","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2026.112602_bb0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The varied roles of notch in Cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Annu. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112602_bb0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/molpharm.120.000006","article-title":"Notch1 in Cancer therapy: possible clinical implications and challenges","volume":"98","author":"Gharaibeh","year":"2020","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112602_bb0090","first-page":"149","article-title":"Notch signaling in prostate cancer: refining a therapeutic opportunity","volume":"31","author":"Su","year":"2016","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.cellsig.2026.112602_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ctrv.2017.04.003","article-title":"The Notch-1 receptor in prostate tumorigenesis","volume":"56","author":"O\u2019Brien","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.cellsig.2026.112602_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9255494","article-title":"Developing ZNF gene signatures predicting radiosensitivity of patients with breast cancer","volume":"2021","author":"Yan","year":"2021","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112602_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12885-023-10779-5","article-title":"Comprehensive analysis of ZNF family genes in prognosis, immunity, and treatment of esophageal cancer","volume":"23","author":"Hong","year":"2023","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112602_bb0110","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/1535-7163.MCT-18-0804","article-title":"Loss of Notch1 activity inhibits prostate cancer growth and metastasis and sensitizes prostate Cancer cells to antiandrogen therapies","volume":"18","author":"Rice","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"37","key":"10.1016\/j.cellsig.2026.112602_bb0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207433119","article-title":"ISL1 is necessary for auditory neuron development and contributes toward tonotopic organization","volume":"119","author":"Filova","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112602_bb0120","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.stemcr.2023.07.002","article-title":"VE-CADHERIN is expressed transiently in early ISL1(+) cardiovascular progenitor cells and facilitates cardiac differentiation","volume":"18","author":"Maltabe","year":"2023","journal-title":"Stem Cell Rep."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112602_bb0125","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00432-021-03634-2","article-title":"Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation","volume":"147","author":"Alshalalfa","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112602_bb0130","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1038\/s41598-021-01003-0","article-title":"ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT)","volume":"11","author":"Choi","year":"2021","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112602_bb0135","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.7150\/thno.62378","article-title":"Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112602_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","article-title":"Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"8095","key":"10.1016\/j.cellsig.2026.112602_bb0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41586-025-09727-z","article-title":"NSD2 targeting reverses plasticity and drug resistance in prostate cancer","volume":"649","author":"Li","year":"2026","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112602_bb0150","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1158\/2159-8290.CD-25-0629","article-title":"Off-pore nucleoporin sPOM121 transcriptionally propels \u03b2-catenin-driven tumor progression and immune escape in prostate Cancer","volume":"15","author":"Kirthika","year":"2025","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112602_bb0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12015-019-09942-y","article-title":"Plasticity of Cancer stem cell: origin and role in disease progression and therapy resistance","volume":"16","author":"Das","year":"2020","journal-title":"Stem Cell Rev. Rep."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:55:28Z","timestamp":1780757728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682600255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S089865682600255X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112602","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZNF503 reduces chemotherapy sensitivity in prostate cancer by activating ISL1 and Notch1 signaling","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112602"}}